
China Pharma Holdings, Inc. – AMEX:CPHI
China Pharma Holdings stock price today
China Pharma Holdings stock price monthly change
China Pharma Holdings stock price quarterly change
China Pharma Holdings stock price yearly change
China Pharma Holdings key metrics
Market Cap | 3.45M |
Enterprise value | N/A |
P/E | -0.43 |
EV/Sales | -0.16 |
EV/EBITDA | 1.61 |
Price/Sales | 0.01 |
Price/Book | 0.03 |
PEG ratio | 0.02 |
EPS | -0.32 |
Revenue | 6.42M |
EBITDA | -1.87M |
Income | -3.55M |
Revenue Q/Q | -30.12% |
Revenue Y/Y | -24.10% |
Profit margin | -52.03% |
Oper. margin | -46.29% |
Gross margin | -7.89% |
EBIT margin | -46.29% |
EBITDA margin | -29.2% |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeChina Pharma Holdings stock price history
China Pharma Holdings stock forecast
China Pharma Holdings financial statements
Jun 2023 | 1.09M | -593.02K | -54.02% |
---|---|---|---|
Sep 2023 | 1.80M | -777.6K | -43.12% |
Dec 2023 | 2.14M | -1.23M | -57.32% |
Mar 2024 | 1.36M | -955.89K | -69.78% |
Jun 2023 | 15704309 | 11.35M | 72.28% |
---|---|---|---|
Sep 2023 | 15352357 | 9.24M | 60.2% |
Dec 2023 | 16469200 | 9.01M | 54.74% |
Mar 2024 | 16190449 | 7.89M | 48.78% |
Jun 2023 | -216.43K | 4.50K | 934 |
---|---|---|---|
Sep 2023 | 1.00M | -67.45K | -476.40K |
Dec 2023 | -22.32K | -4.52K | 30.37K |
Mar 2024 | -585.15K | 0 | 6.85K |
China Pharma Holdings alternative data
Aug 2023 | 234 |
---|---|
Sep 2023 | 234 |
Oct 2023 | 234 |
Nov 2023 | 234 |
Dec 2023 | 234 |
Jan 2024 | 234 |
Feb 2024 | 234 |
Mar 2024 | 234 |
Apr 2024 | 234 |
May 2024 | 231 |
Jun 2024 | 231 |
Jul 2024 | 231 |
China Pharma Holdings other data
Period | Buy | Sel |
---|---|---|
Oct 2005 | 0 | 1828170 |
Quarter | Transcript |
---|---|
Q4 2019 31 Mar 2020 | Q4 2019 Earnings Call Transcript |
Q2 2019 15 Aug 2019 | Q2 2019 Earnings Call Transcript |
Q1 2019 15 May 2019 | Q1 2019 Earnings Call Transcript |
Q4 2018 29 Mar 2019 | Q4 2018 Earnings Call Transcript |
-
What's the price of China Pharma Holdings stock today?
One share of China Pharma Holdings stock can currently be purchased for approximately $1.42.
-
When is China Pharma Holdings's next earnings date?
Unfortunately, China Pharma Holdings's (CPHI) next earnings date is currently unknown.
-
Does China Pharma Holdings pay dividends?
No, China Pharma Holdings does not pay dividends.
-
How much money does China Pharma Holdings make?
China Pharma Holdings has a market capitalization of 3.45M and it's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 13.48% to 7.01M US dollars.
-
What is China Pharma Holdings's stock symbol?
China Pharma Holdings, Inc. is traded on the AMEX under the ticker symbol "CPHI".
-
What is China Pharma Holdings's primary industry?
Company operates in the Healthcare sector and Drug Manufacturers - Specialty & Generic industry.
-
How do i buy shares of China Pharma Holdings?
Shares of China Pharma Holdings can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are China Pharma Holdings's key executives?
China Pharma Holdings's management team includes the following people:
- Ms. Zhilin Li Pres, Chief Executive Officer, Chairman & Interim Chief Financial Officer(age: 72, pay: $241,600)
-
How many employees does China Pharma Holdings have?
As Jul 2024, China Pharma Holdings employs 231 workers, which is 1% less then previous quarter.
-
When China Pharma Holdings went public?
China Pharma Holdings, Inc. is publicly traded company for more then 23 years since IPO on 17 Apr 2002.
-
What is China Pharma Holdings's official website?
The official website for China Pharma Holdings is chinapharmaholdings.com.
-
How can i contact China Pharma Holdings?
China Pharma Holdings can be reached via phone at +86 898 6681 1730.
China Pharma Holdings company profile:

China Pharma Holdings, Inc.
chinapharmaholdings.comAMEX
231
Drug Manufacturers - Specialty & Generic
Healthcare
China Pharma Holdings, Inc. develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products primarily to hospitals and private retailers in the People's Republic of China. The company offers products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. Its products include Cerebroprotein Hydroloysate injection to treat memory decline and attention deficit; Gastrodin injection for tiredness, loss of concentration, poor sleep, and traumatic syndromes of the brain; Propylgallate and Ozagrel Sodium to treat cerebral thrombosis, coronary heart disease, and after surgery complications; Alginic Sodium Diester injection for ischemic heart, cerebrovascular, and high lipoprotein blood diseases; Bumetanide injection to treat edema diseases; and Candesartan for hypertension. It also provides Roxithromycin dispersible tablets for pharyngitis and tonsillitis; Cefaclor dispersible tablets for tympanitis, lower respiratory tract infection, urinary tract infections, and skin/skin tissue infection; Cefalexin capsules for acute tonsillitis; Andrographolide for sore throat caused by upper respiratory tract infection; Clarithromycin granules and capsules; and Naproxen Sodium and PseudophedrineHydrochlorida sustained release tablets. In addition, the company offers Hepatocyte growth-promoting factor, Tiopronin, Compound Ammonium Glycyrrhetate S, and Omeparzole for the treatment of digestive diseases. Further, it provides Vitamin B6 injection; Granisetron Hydrochloride injection to treat nausea and vomiting caused by radiotherapy and chemotherapy during the treatment of malignant tumors; Noni Enzyme, a food supplement; sanitizers; and masks. The company offers its products through distributors, as well as through its network of 16 sales offices and approximately 1,000 sales representatives. China Pharma Holdings, Inc. was founded in 1993 and is based in Haikou, the People's Republic of China.
Haikou, 570216
CIK: 0001106644
ISIN: US16941T2033
CUSIP: 16941T104